UnitedHealth

UnitedHealth Group Reports 2023 Results — Revenues of $371.6 Billion Grew 15% Year-Over-Year — Earnings from Operations Grew 14% — Cash Flows from Operations were $29.1 Billion or 1.3x Net Income — Full Year and Fourth Quarter Net Earnings were $23.86 and $5.83 Per Share — Full Year and Fourth Quarter Adjusted Net Earnings were $25.12 and $6.16 Per Share UnitedHealth Group (NYSE: UNH) reported full year and fourth quarter 2023 results reflecting broad-based growth at Optum and UnitedHealthcare. This press release features multimedia. View the full release here: UnitedHealth Group corporate headquarters (Photo: Business Wire) “UnitedHealth Group enters 2024 well prepared to build on our efforts to improve patient care and consumer experiences broadly, and to continue delivering strong and balanced growth,” said Andrew Witty, chief executive officer of UnitedHealth Group. UnitedHealth Group affirmed the 2024 performance objectives established at its November 29(th) Investor Conference, excluding the potential impacts […]

The following is a summary of the UnitedHealth Group Incorporated (UNH) Q4 2023 Earnings Call Transcript: Financial Performance: UnitedHealth reported 2023 revenue of $372 billion, a growth of over 14% with double-digit growth achieved by both Optum and UnitedHealthcare. Fourth quarter adjusted earnings per share of $6.16 grew 15%, leading to a 13% growth in the full-year adjusted earnings per share, which reached $25.12. Due to the sale of Brazil operations, the company expects to record a charge of approximately $7 billion, primarily stemming from non-cash foreign currency translation losses. The cash flow from operations in 2023 reached $29 billion or 1.3 times the net income. The company returned nearly $15 billion to shareholders through share repurchase and dividends and set aside over $10 billion in growth capital for future development. Business Progress: UnitedHealth added 900,000 new members to value-based care arrangements, bringing the total count to over 4.1 million.

UnitedHealth Group (NYSE:UNH) is set to give its latest quarterly earnings report on Friday, 2024-01-12. Here’s what investors need to know before the announcement. Analysts estimate that UnitedHealth Group will report an earnings per share (EPS) of $5.98. UnitedHealth Group bulls will hope to hear the company announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter. New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

By Josh Nathan-Kazis The managed care giant UnitedHealth Group kicks off the earnings season for healthcare companies Friday morning. Investors will watch closely for updates on how intensely patients used healthcare services in the last quarter of the year, a key bellwether for the healthcare sector. Higher-than-expected utilization of medical services by patients enrolled in Medicare Advantage plans over the past year has periodically sparked worries among investors in recent months. UnitedHealth’s medical loss ratio for the fourth quarter, or MLR — which tracks the proportion of premiums paid out to cover medical expenses — will be closely watched. A higher MLR means more spending on medical expenses, and less room for profit. Analysts expect UnitedHealth to report an MLR of 84.1% for the fourth quarter, according to FactSet, higher than the 82.8% paid out in the same quarter in 2022. Nevertheless, Wall Street projects UnitedHealth will report earnings of

UnitedHealth Group (NYSE:UNH) Analyst Ratings Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 12/18/2023 -8.92% HSBC $550 → $480 Downgrades Hold → Reduce 12/13/2023 11% Stephens & Co. → $585 Reiterates Overweight → Overweight 11/30/2023 15.75% Truist Securities → $610 Reiterates Buy → Buy 11/30/2023 13.09% RBC Capital → $596 Reiterates Outperform → Outperform 11/30/2023 11% Stephens & Co. → $585 Reiterates Overweight → Overweight 11/21/2023 12.14% Cantor Fitzgerald → $591 Reiterates Overweight → Overweight 11/20/2023 -4.56% Jefferies $565 → $503 Maintains Hold 10/23/2023 9.87% Morgan Stanley $587 → $579 Maintains Overweight 10/16/2023 13.09% RBC Capital $572 → $596 Maintains Outperform 10/16/2023 10.81% Piper Sandler $580 → $584 Maintains Overweight 10/16/2023 21.44% UBS → $640 Upgrades Neutral → Buy 10/09/2023 0.76% Jefferies $529 → $531 Maintains Hold 09/14/2023 12.14% Cantor Fitzgerald → $591 Reiterates Overweight → Overweight 09/06/2023 2.46% HSBC → $540 Initiates Coverage On

HSBC analyst Rajesh Kumar downgrades UnitedHealth Group (NYSE:UNH) from Hold to Reduce and lowers the price target from $550 to $480.

Piper Sandler analyst Jessica Tassan maintains UnitedHealth Group (NYSE:UNH) with a Overweight and raises the price target from $580 to $584.

UBS analyst Kevin Caliendo upgrades UnitedHealth Group (NYSE:UNH) from Neutral to Buy and announces $640 price target.

CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lift our 12-month target price to $595 from $526, reflecting 21.3x our 2024 EPS estimate, a premium to UNH’s historical forward average given a strong EPS growth outlook. We widen our 2023 adj. EPS estimate to $24.88 from $24.78 and narrow our 2024 estimate to $27.95 from $28.17. UNH reported Q3 adj. EPS of $6.56 vs. $5.79, beating the consensus view by $0.21. The third quarter’s outperformance was driven by strong sales growth from Optum (+22% Y/Y) due to an increase in the number of care services offered and patients served, especially for those with complex care needs, in addition to strengthening operating margins in the UnitedHealthcare business. Given the strong year-to-date performance, UNH was able to lift its 2023 EPS guidance, and we see the

UnitedHealth Group Exec Says Expects To Add An Additional 1M People To Commercial Insurance Business In 2024; Co Is Confident In Its Long-Term 13% To 16% Growth Objective。

UnitedHealth Q3 Revenue $92.361 Bln Vs. $80.894 Bln a Year Ago; FactSet Consensus $91.414 Bln。